AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance

Authors:

Abstract
No abstract available
Funding Information
  • GlaxoSmithKline Biologicals

This publication has 53 references indexed in Scilit: